Mission Bay Open House and Panel Discussion
This joint QB3 and BayBio event will provide a rare opportunity for Northern California life sciences companies to tour core facilities at UCSF Mission Bay and to learn about the state-of-the-art support services and technologies they provide, as well as their availability to aid commercial scientific research and investigative teams. A distinguished panel of experts will examine the benefits of industry, academia and venture collaboration for improving translational research following the tours.
| What: | Mission Bay Open House and Panel Discussion |
| When: | June 29, 2010 UCSF Core Facilities Tours and Poster Sessions: 3:00pm – 5:00pm Panel Discussion: Mission Bay on a Mission: 5:00pm – 6:00pm Networking Reception: 6:00 – 7:00pm |
| Where: | UCSF Mission Bay 1700 4th St, Byers Hall, San Francisco, CA Directions |
| Parking: | Garage parking available $3/hr |
| Attire: | Business attire suggested |
| Cost: | SOLD OUT | Tours Only: $20 BayBio Members | $40 Non-Members SOLD OUT | Tours, Panel Discussion and Reception: $40 Members | $75 Non-Members |
Nikon Imaging Center**
Cell Culture Facility
Core Immunoassay Laboratory
Small Molecule Discovery Center**
MicroCT
NMR Center**
Center for BioEntrepreneurship
Lab for Cell Analysis**
Preclinical Therapeutics
Lentiviral Core
ARI-UCSF Laboratory of Clinical Virology
CFAR CTSI-TTR Core Immunology Laboratory
CTSI Clinical Research Services
DNA Bank
Earl Miller Radiologic Imaging Laboratory
Genomics Core Facility
Gladstone Genomics Core
Gladstone Histology Core
Gladstone Stem Cell Core
Human Islet and Cellular Transplantation Facility
Neurobehavioral Core for Rehabilitation Research
Preclinical Fluorescence Imaging Laboratory
Biomagnetic Imaging Core
**Participating in core facility tours
Mission Bay on a Mission
A panel of remarkable biotech leaders will explore how unique collaboration between university, venture capital and corporations can improve translational medicine and accelerate bringing improved products and services to society. The panel will explore how these partners in life science product development can be matched more efficiently, and how product development costs can be lowered and R&D process can be further de-risked.
Panel Participants:
Brook Byers
Partner, Kleiner Perkins Caufield & Byers
Susan Desmond-Hellmann
Chancellor, UCSF
Regis Kelly
Director, QB3
Gail Maderis
President and CEO, BayBio
Uwe Schoenbeck
CSO, BioTherapeutics External R&D Innovation, Pfizer, Inc.
